Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030

Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030

The Biologics Market size was estimated at USD 287.45 billion in 2023 and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030.

Global Biologics Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biologics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biologics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biologics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen MA Inc., BioPharm Laboratories, LLC, Bristol Myers Squibb Company, Catalent, Inc, Celltrion Healthcare Co., Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc., Gilead Sciences, Inc., GlaxoSmithKline PLC, Innovent Biologics, Inc., Johnson & Johnson Services, Inc., Merck KGaA, Novartis AG, Pfizer Inc., Samsung Biologics Co.,Ltd., Sanofi S.A., Thermo Fisher Scientific Inc., Vertex Pharmaceuticals, Inc., and WuXi Biologics Co., Ltd..

Market Segmentation & Coverage



This research report categorizes the Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Cellular Based Biologics
Gene Based Biologics
Monoclonal Antibodies
Diagnostic
Biochemical Analysis
Diagnostic Imaging
Therapeutic
Direct MAB Agents
Targeting MAB Agents
Recombinant Hormones or Proteins
Vaccines
Indication
Autoimmune Diseases
Cancer
Infectious Diseases
Rare Diseases
End-user
Ambulatory Surgical Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biologics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biologics Market?
3. What are the technology trends and regulatory frameworks in the Biologics Market?
4. What is the market share of the leading vendors in the Biologics Market?
5. Which modes and strategic moves are suitable for entering the Biologics Market?

Note: PDF & Excel + Online Access - 1 Year